SEC 13F Intelligence

Neuberger Berman Group LLC / ABBV

Neuberger Berman Group LLC’s Abbvie Inc Position

Does Neuberger Berman Group LLC own Abbvie Inc (ABBV)? Yes — 1.23M shares worth $269M (+0.20% of its 13F portfolio) as of Q1 2026, up from 1.18M shares the prior filed quarter.

Position Value
$269M
Q1 2026
Shares
1.23M
% of Portfolio
+0.20%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $50MQ4 ’18Q1 ’19: $39MQ2 ’19: $35MQ3 ’19: $34MQ4 ’19: $41MQ4 ’19Q1 ’20: $41MQ2 ’20: $91MQ3 ’20: $75MQ4 ’20: $68MQ4 ’20Q1 ’21: $114MQ2 ’21: $166MQ3 ’21: $101MQ4 ’21: $146MQ4 ’21Q1 ’22: $184MQ2 ’22: $183MQ3 ’22: $139MQ4 ’22: $254MQ4 ’22Q1 ’23: $281MQ2 ’23: $215MQ3 ’23: $234MQ4 ’23: $245MQ4 ’23Q1 ’24: $338MQ2 ’24: $335MQ3 ’24: $439MQ4 ’24: $264MQ4 ’24Q1 ’25: $288MQ2 ’25: $230MQ3 ’25: $275MQ4 ’25: $270MQ4 ’25Q1 ’26: $269Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.23M$269M+0.20%
Q4 20251.18M$270M+0.20%
Q3 20251.19M$275M+0.20%
Q2 20251.24M$230M+0.18%
Q1 20251.37M$288M+0.24%
Q4 20241.48M$264M+0.21%
Q3 20242.22M$439M+0.34%
Q2 20241.95M$335M+0.27%
Q1 20241.85M$338M+0.28%
Q4 20231.58M$245M+0.21%
Q3 20231.57M$234M+0.21%
Q2 20231.60M$215M+0.19%
Q1 20231.77M$281M+0.26%
Q4 20221.57M$254M+0.25%
Q3 20221.03M$139M+0.15%
Q2 20221.19M$183M+0.18%
Q1 20221.14M$184M+0.16%
Q4 20211.12M$146M+0.11%
Q3 2021972.9K$101M+0.09%
Q2 20211.51M$166M+0.14%
Q1 20211.06M$114M+0.11%
Q4 2020635.0K$68M+0.07%
Q3 2020860.3K$75M+0.09%
Q2 2020923.9K$91M+0.11%
Q1 2020541.6K$41M+0.06%
Q4 2019463.7K$41M+0.05%
Q3 2019454.5K$34M+0.04%
Q2 2019479.8K$35M+0.04%
Q1 2019482.3K$39M+0.05%
Q4 2018538.4K$50M+0.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neuberger Berman Group LLC’s full portfolio or all institutional holders of ABBV.